Mounjaro vs Zepbound Constipation: Is There a Difference?

If you are on Mounjaro and a friend is on Zepbound, you may wonder whether one of you got the “gentler” drug. When you are dealing with constipation, it is a fair question. The short answer: the medication is the same, so the constipation is too. What differs is the context around it, and that is where you can make real progress.

Mounjaro and Zepbound are the same drug

Both brands contain tirzepatide, a dual GIP and GLP-1 receptor agonist made by Eli Lilly. Mounjaro is approved for type 2 diabetes. Zepbound is approved for chronic weight management (and, more recently, obstructive sleep apnea in adults with obesity). The dose strengths are the same: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg once weekly.

Because the active ingredient and dosing ladder match, there is no pharmacological reason one brand would cause more constipation than the other. Any difference you hear about is usually about the people taking each brand, not the molecule.

What the trial data says about constipation

In the SURMOUNT-1 trial of tirzepatide for weight management, constipation was among the most commonly reported gastrointestinal side effects, along with nausea, diarrhea and vomiting. In the SURPASS diabetes trials, which led to Mounjaro, GI side effects followed a similar pattern. Most were mild to moderate and clustered around the start of treatment and each dose increase.

Exact percentages vary by dose and trial, so check the current prescribing information for the numbers. The takeaway is consistent: constipation is common on tirzepatide whichever brand name is on your box.

Why people feel a difference between brands

Even with identical medication, a few things can make the experience differ.

• Different patients. People taking Zepbound for weight loss may be eating much less, which means less food volume and less fiber moving through the gut. People on Mounjaro for diabetes may be managing other medications that affect digestion.
• Different dose paths. Some prescribers move patients up faster than others. Constipation often flares right after a dose increase.
• Pen versus vial. Zepbound is also sold in single-dose vials through the manufacturer’s direct program. The medication is identical, but the delivery format does not change how it affects your gut.
• Diet changes. Eating far less, drinking less water, and skipping vegetables are bigger drivers of constipation than the brand name.

Why tirzepatide slows things down

GLP-1 and GIP signaling slows gastric emptying and can slow movement through the colon. Food spends longer in your system, so more water is absorbed from stool and it becomes harder to pass. Add reduced appetite, lower fluid intake and less fiber, and constipation becomes likely. This is a mechanism of the drug class, which is why it shows up on every GLP-1 and tirzepatide product.

What helps on either brand

These steps apply whether your pen says Mounjaro or Zepbound:

1. Drink more water. Aim for steady fluids through the day, not only with meals. Ask your provider about a target if you have kidney or heart conditions.
2. Build fiber gradually. Raise it slowly toward the general recommendation of roughly 25 to 35 grams a day, mixing soluble fiber (oats, chia, psyllium) with insoluble sources (vegetables, berries). Jumping too fast can worsen bloating.
3. Keep protein high but balanced. Protein protects muscle, but a protein-only plan with no fiber makes constipation worse.
4. Move daily. Even a 15-minute walk after meals helps your gut.
5. Time your routine. Try to use the bathroom at the same time each day, often after breakfast.
6. Ask about over-the-counter options. Osmotic laxatives or magnesium may be suitable, but check with your prescriber or pharmacist first.

When to call your provider

Constipation is usually manageable, but do not wait it out if you have severe abdominal pain, persistent vomiting, a swollen belly, blood in the stool, or no bowel movement for several days. These can signal a more serious problem. Never stop or change your dose without talking to your care team.

Keep going with relief that fits your dose

If your constipation spikes when you move up a dose, our post on Zepbound and Mounjaro constipation relief when you increase your dose walks through what to do at each step. For the early weeks, see Mounjaro side effects in weeks 1 to 4.

Want a complete, patient-friendly plan? The GLP-1 Constipation Relief Guide ($21.97) gives you daily routines, food lists and a dose-day checklist built for people on tirzepatide and semaglutide. You can also see every guide and bundle on the checkout page.

This article is educational and not medical advice. Talk with your prescriber about your symptoms and treatment.